Comments
Daiichi Sankyo, GlaxoSmithKline set up Japan JV
02.03.2012. | TOKYO (Reuters) - Japan's Daiichi Sankyo Co said on Friday it will form a 50-50 joint venture with Britain's GlaxoSmithKline PLC to bring new vaccines to the Japanese market, which is known for its slow acceptance of vaccines....
